Literature DB >> 12969786

Inhibition of inducible isoforms of cyclooxygenase and nitric oxide synthase by flavonoid hesperidin in mouse macrophage cell line.

Keiko Sakata1, Yoshinobu Hirose, Zheng Qiao, Takuji Tanaka, Hideki Mori.   

Abstract

Previous data have shown that a citrus flavanone, hesperidin possesses chemopreventive efficacies. We designed to investigate the inhibitory effect of hesperidin on lipopolysaccharide (LPS)-induced over-expression of cyclooxygenase-2 (COX-2), inducible nitric oxide synthase (iNOS) proteins, over-production of prostaglandin E2 (PGE2) and nitric oxide (NO) using mouse macrophage cells. Treatment with hesperidin suppressed production of PGE2, nitrogen dioxide (NO2), and expression of iNOS protein. In the case of COX-2, hesperidin did not affect the protein level. Our data indicate hesperidin as a COX-2 and iNOS inhibitor, which might be related to the anti-inflammatory and anti-tumorigenic efficacies.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12969786     DOI: 10.1016/s0304-3835(03)00386-0

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  20 in total

1.  Comparative study of the vasorelaxant activity, superoxide-scavenging ability and cyclic nucleotide phosphodiesterase-inhibitory effects of hesperetin and hesperidin.

Authors:  Francisco Orallo; Ezequiel Alvarez; Hélène Basaran; Claire Lugnier
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-11-17       Impact factor: 3.000

2.  Hesperidin as a preventive resistance agent in MCF-7 breast cancer cells line resistance to doxorubicin.

Authors:  Rifki Febriansah; Dyaningtyas Dewi Pamungkas Putri; Nunuk Aries Nurulita; Edy Meiyanto; Agung Endro Nugroho
Journal:  Asian Pac J Trop Biomed       Date:  2014-03

3.  Protective effects of hesperidin and diosmin against acrylamide-induced liver, kidney, and brain oxidative damage in rats.

Authors:  Abdelazim E Elhelaly; Gadah AlBasher; Saleh Alfarraj; Rafa Almeer; Eshak I Bahbah; Maged M A Fouda; Simona G Bungău; Lotfi Aleya; Mohamed M Abdel-Daim
Journal:  Environ Sci Pollut Res Int       Date:  2019-11-04       Impact factor: 4.223

4.  Effect of lipopolysaccharide on diarrhea and gastrointestinal transit in mice: roles of nitric oxide and prostaglandin E2.

Authors:  Yu-Chih Liang; Hung-Jung Liu; Sheng-Hsuan Chen; Chun-Chin Chen; Liang-Shung Chou; Li Hsueh Tsai
Journal:  World J Gastroenterol       Date:  2005-01-21       Impact factor: 5.742

5.  Quercetin protects ARPE-19 cells against photic stress mediated by the products of rhodopsin photobleaching.

Authors:  Magdalena M Olchawa; Olga I Krzysztynska-Kuleta; Krystian T Mokrzynski; Piotr M Sarna; Tadeusz J Sarna
Journal:  Photochem Photobiol Sci       Date:  2020-06-26       Impact factor: 3.982

6.  Effect of hesperidin on mice bearing Ehrlich solid carcinoma maintained on doxorubicin.

Authors:  Naglaa F Khedr; Rania M Khalil
Journal:  Tumour Biol       Date:  2015-06-23

Review 7.  Potential of the bioflavonoids in the prevention/treatment of ocular disorders.

Authors:  Soumyajit Majumdar; Ramesh Srirangam
Journal:  J Pharm Pharmacol       Date:  2010-08       Impact factor: 3.765

Review 8.  Signal transduction and molecular targets of selected flavonoids.

Authors:  Ann M Bode; Zigang Dong
Journal:  Antioxid Redox Signal       Date:  2013-04-15       Impact factor: 8.401

9.  Suppressive Effect on Lipopolysaccharide-Induced Proinflammatory Mediators by Citrus aurantium L. in Macrophage RAW 264.7 Cells via NF-κB Signal Pathway.

Authors:  Sang-Rim Kang; Dae-Yong Han; Kwang-Il Park; Hyeon-Soo Park; Yong-Bae Cho; Hu-Jang Lee; Won-Sup Lee; Chung Ho Ryu; Yeong Lae Ha; Do Hoon Lee; Jin A Kim; Gon-Sup Kim
Journal:  Evid Based Complement Alternat Med       Date:  2010-09-21       Impact factor: 2.629

10.  The Traditional Japanese Medicine Rikkunshito Promotes Gastric Emptying via the Antagonistic Action of the 5-HT(3) Receptor Pathway in Rats.

Authors:  K Tominaga; T Kido; M Ochi; C Sadakane; A Mase; H Okazaki; H Yamagami; T Tanigawa; K Watanabe; T Watanabe; Y Fujiwara; N Oshitani; T Arakawa
Journal:  Evid Based Complement Alternat Med       Date:  2011-02-13       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.